CRVS
CRVS
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
1
$50K
Insider Sales
0
$0
Total Volume
$50K
1 transactions
Net Activity
+$50K
Net buying
Sentiment Rating
Moderate AccumulationCEO Conviction Index
No Recent Signal
Key Drivers
- •Strong buying bias: purchases represent 100% of total transaction value.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Arcara Jeffrey
Chief Business Officer
$50K total
Quick Actions
CRVS has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%. CRVS ranks #493 in insider activity out of 569 tracked companies in its industry.
Over the last 90 days, corporate insiders at CRVS (CRVS) engaged in a total of 1 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 0 were sales. The total volume of insider trading reached $50K.
The net insider activity for CRVS shows a net buying bias of $50K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Purchase by Arcara Jeffrey (Chief Business Officer), who traded 4.5K shares valued at $50K on Nov 11, 2026.
CRVS - Corvus Pharmaceuticals Inc Stock Price and Quote
Why Corvus Pharmaceuticals (CRVS) Is Up 211.8% After Upsized Equity Raise On Soquelitinib Phase 2 Plans
A London conference webcast will remain available for 90 days after Corvus presents.
Soquelitinib Data Push Corvus Pharmaceuticals Stock Higher: What You Should Know (CRVS)
Corvus Pharmaceuticals: CRVS Stock Price Quote & News
Insider Buys Additional US$250k In Corvus Pharmaceuticals Stock
FAQs About CRVS Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for CRVS.